Georgia-savina Moysidou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease.

Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease.

Journal: Annals of the rheumatic diseases

Published: May 22, 2026

Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response.

Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response.

Journal: Journal of autoimmunity

Published: September 18, 2025

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: February 16, 2025

Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.

Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.

Journal: Rheumatology international

Published: January 13, 2025

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways.

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways.

Journal: Annals of the rheumatic diseases

Published: May 01, 2024

Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis.

Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis.

Journal: Diagnostics (Basel, Switzerland)

Published: February 27, 2024

EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward.

EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward.

Journal: Mediterranean journal of rheumatology

Published: January 13, 2024

Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis.

Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis.

Journal: Clinical rheumatology

Published: January 11, 2024

JAK Inhibition as a Potential Treatment Target in Systemic Lupus Erythematosus.

JAK Inhibition as a Potential Treatment Target in Systemic Lupus Erythematosus.

Journal: Mediterranean journal of rheumatology

Published: November 23, 2023

Management of systemic lupus erythematosus: A new scenario.

Management of systemic lupus erythematosus: A new scenario.

Journal: Best practice & research. Clinical rheumatology

Published: August 31, 2023

Understanding and managing cardiac involvement in systemic sclerosis.

Understanding and managing cardiac involvement in systemic sclerosis.

Journal: Expert review of clinical immunology

Published: January 23, 2023

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.

Journal: Lupus

Published: December 09, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026